⚠️ Regulation Tightens on Pharma Manufacturing

As a physician, patient safety is always front and centre—and recent regulatory action in India demands our attention. The Central Drugs Standard Control Organisation (CDSCO) has mandated that all pharmaceutical manufacturers must meet international standards by January 1, 2026—following a tragic series of child deaths linked to contaminated cough syrups.
This means major upgrades in manufacturing protocols: cross-contamination prevention, batch testing, and stricter compliance. For us in clinical practice, this reinforces the importance of prescribing medicines from manufacturers with verifiable standards—and reporting even minor adverse events so the safety net holds strong.